CalciMedica, Inc. (CALC)
NASDAQ: CALC · Real-Time Price · USD
1.450
+0.020 (1.40%)
At close: Jun 27, 2025, 4:00 PM
1.430
-0.020 (-1.38%)
After-hours: Jun 27, 2025, 4:09 PM EDT
CalciMedica Employees
CalciMedica had 14 employees as of December 31, 2024. The number of employees increased by 2 or 16.67% compared to the previous year.
Employees
14
Change
2
Growth
16.67%
Revenue / Employee
n/a
Profits / Employee
-$1,348,000
Market Cap
19.98M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 14 | 2 | 16.67% |
| Dec 31, 2021 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CALC News
- 3 days ago - CalciMedica Announces Publication in the American Journal of Nephrology Discussing Design and Rationale of Phase 2 KOURAGE Trial of Auxora™ in AKI with Respiratory Failure - PRNewsWire
- 16 days ago - CalciMedica Announces Upcoming Symposium at the 43rd Vicenza Course AKI-CRRT-EBPT and Critical Care Nephrology Meeting - PRNewsWire
- 6 weeks ago - CalciMedica Reports First Quarter 2025 Financial Results and Provides Clinical & Corporate Updates - PRNewsWire
- 2 months ago - CalciMedica Announces Presentations at Upcoming Medical Meetings - PRNewsWire
- 3 months ago - CalciMedica to Participate in the Jones Healthcare and Technology Innovation Conference - PRNewsWire
- 3 months ago - CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates - PRNewsWire
- 4 months ago - CalciMedica Secures Credit Facility for Up to $32.5 Million - PRNewsWire
- 4 months ago - CalciMedica Presents AKI Data from a Post-Hoc Analysis of the Phase 2 CARDEA trial of Auxora™ in Severe COVID-19 Pneumonia at the 30th International AKI & CRRT Conference - PRNewsWire